These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23597)

  • 21. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
    Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
    J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
    [No Abstract]   [Full Text] [Related]  

  • 24. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary tumor virus (MTV) antigens in normal and mammary tumor-bearing mice.
    Hilgers JH; Theuns GJ; van Nie R
    Int J Cancer; 1973 Nov; 12(3):568-76. PubMed ID: 4364792
    [No Abstract]   [Full Text] [Related]  

  • 26. An alteration in tumor histocompatibility induced by neuraminidase.
    Sanford BH
    Transplantation; 1967 Sep; 5(5):1273-9. PubMed ID: 6056941
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological studies on mouse mammary tumors. II. Characterization of tumor-specific antibodies against mouse mammary tumors.
    Takeuchi S; Irie RF; Inoue M; Irie K; Izumi R; Nishioka K
    Int J Cancer; 1969 Mar; 4(2):130-8. PubMed ID: 5347282
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological studies on mouse mammary tumors. IV. Extraction and solubilization of transplantation antigen of mouse mammary tumor.
    Irie RF; Nishioka K; Tachibana T; Takeuchi S
    Int J Cancer; 1969 Mar; 4(2):150-8. PubMed ID: 5347284
    [No Abstract]   [Full Text] [Related]  

  • 29. Induced alteration of resistance to transplantable mammary adenocarcinoma in mice neonatally inoculated with rat thymus antiserum.
    Anigstein L; Anigstein DM; Rennels EG; O'Steen WK
    Cancer Res; 1966 Sep; 26(9):1867-72. PubMed ID: 5924952
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial characterization of an antigen in spontaneous murine mammary tumors.
    Tacker JR; Hyde RM
    Int J Cancer; 1969 Jan; 4(1):21-30. PubMed ID: 4981365
    [No Abstract]   [Full Text] [Related]  

  • 33. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL; Miller GF; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):289-301. PubMed ID: 4303881
    [No Abstract]   [Full Text] [Related]  

  • 34. Mammary tumor virus-associated antigenicity of L-1210 murine leukemia cells.
    Kisielow P; Radzikowski C; Steuden J; Szkudlarek J; Krawczynski K
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):789-99. PubMed ID: 4335186
    [No Abstract]   [Full Text] [Related]  

  • 35. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
    Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
    Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 37. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 40. Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
    Salup RR; Toth JA; Hiserodt JC; Wolmark N
    Prog Clin Biol Res; 1987; 244():39-48. PubMed ID: 2958875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.